Business Description
Nemaura Medical Inc
NAICS : 339112
SIC : 5047
ISIN : US6404421090
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -3.45 | |||||
Debt-to-Equity | -1.1 | |||||
Debt-to-EBITDA | -4.37 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -8.9 | |||||
3-Year EPS without NRI Growth Rate | -44.7 | |||||
3-Year FCF Growth Rate | -27.1 | |||||
3-Year Book Growth Rate | -86.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.05 | |||||
9-Day RSI | 36.05 | |||||
14-Day RSI | 40.14 | |||||
6-1 Month Momentum % | -68.54 | |||||
12-1 Month Momentum % | -91.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.19 | |||||
Quick Ratio | 0.03 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 644.11 | |||||
Days Payable | 75.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.5 | |||||
Shareholder Yield % | 74.42 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -12651.95 | |||||
ROA % | -106.37 | |||||
ROIC % | -56.93 | |||||
3-Year ROIIC % | -20.92 | |||||
ROC (Joel Greenblatt) % | -386.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.91 | |||||
EV-to-EBIT | -4.12 | |||||
EV-to-EBITDA | -4.56 | |||||
EV-to-Revenue | 266.42 | |||||
EV-to-Forward-Revenue | 14.86 | |||||
EV-to-FCF | -2.12 | |||||
Earnings Yield (Greenblatt) % | -24.27 | |||||
FCF Yield % | -1016.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NMRD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nemaura Medical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.077 | ||
EPS (TTM) ($) | -0.39 | ||
Beta | 1.21 | ||
Volatility % | 78.89 | ||
14-Day RSI | 40.14 | ||
14-Day ATR ($) | 0.007848 | ||
20-Day SMA ($) | 0.028625 | ||
12-1 Month Momentum % | -91.75 | ||
52-Week Range ($) | 0.015 - 0.39 | ||
Shares Outstanding (Mil) | 40.35 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nemaura Medical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nemaura Medical Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Nemaura Medical Inc Frequently Asked Questions
What is Nemaura Medical Inc(NMRD)'s stock price today?
When is next earnings date of Nemaura Medical Inc(NMRD)?
Does Nemaura Medical Inc(NMRD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |